Syncom Formulations

Sector: Healthcare

Followers

7
7
3
3
.
3
3
1
1
-0.19 (-1.40%)

As on 13 Apr, 2026 | 15:59

Open Trading A/c
Day Range
12.89
13.55
LH
52 Week Range
10.21
23.49
LH
Volume
* i
Bid / Ask
2,668,205.00
0.00 / 0.00

Syncom Formulations Announcements

<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Syncom...

07 Apr, 2026 | 04:03pm • Source: BSE

Certificate for compliance of regulation 74(5) of the SEBI (Depositories and participants) Regulation, 2018 for the quarter ended 31st March, 2026

07 Apr, 2026 | 01:49pm • Source: BSE

Pursuant to the regulation 31(4) of SEBI (SAST) Regulations, 2011, we would like to inform that the following promoters along with their persons acting in...

06 Apr, 2026 | 05:47pm • Source: BSE

<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Syncom...

03 Apr, 2026 | 04:07pm • Source: BSE

Pursuant to SEBI (PIT) Regulation, 2015 as amended till date, the window for trading in the shares of the company shall remain closed form 1st...

25 Mar, 2026 | 04:47pm • Source: BSE

Submission of Press Clipping Related to extract of Un-Audited Financial Result for the Quarter and Nine months ended on 31st December, 2025

13 Feb, 2026 | 01:49pm • Source: BSE

Submission of Unaudited standalone and Consolidated Financials as an outcome of Board meeting held on 12th February, 2026

12 Feb, 2026 | 04:43pm • Source: BSE

Syncom Formulations India Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2026 ,inter alia, to consider...

04 Feb, 2026 | 01:23pm • Source: BSE

Certificate for compliance of regulation 74(5) of the SEBI (Depositories and Participants) Regulation, 2018 for the quarter ended 31st December, 2025

08 Jan, 2026 | 03:24pm • Source: BSE

Certificate for compliance of regulation 74(5) of the SEBI (Depositories and participants) regulation, 2018 for the quarter ended 31st December, 2025.

08 Jan, 2026 | 03:12pm • Source: BSE

Closure of Trading Window for the quarter ending 31.12.2025 pursuant to SEBI(PIT)REG, 2015

26 Dec, 2025 | 05:26pm • Source: BSE

Submission of Unaudited Standalone and consolidated Financial results for the Quarter ended 30.09.2025

12 Nov, 2025 | 05:22pm • Source: BSE

This is in continuation of our letter no. SYNCOM/SE/2025-26 dated 7th November, 2025 regarding intimation of Board meeting for consideration and approval of Standalone and...

12 Nov, 2025 | 05:14pm • Source: BSE

Syncom Formulations India Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2025 ,inter alia, to consider...

07 Nov, 2025 | 05:41pm • Source: BSE

Certificate for compliance of Regulation 74(5) of SEBI (Depositories and Participants) Regulation 2018 for the quarter ended 30th September, 2025

16 Oct, 2025 | 06:19pm • Source: BSE

Appointment of Secretarial Auditor confirmed in 37th AGM

01 Oct, 2025 | 06:09pm • Source: BSE

Alteration in MOA and AOA as approved in the 37th AGM

01 Oct, 2025 | 06:06pm • Source: BSE

Change in Management_Appointment of Chairman and Secreterial Auditor as confirmed in the 37th Annual general Meeting

01 Oct, 2025 | 06:00pm • Source: BSE

Outcome of 37th Annual General meeting held on 29th Sep, 2025

01 Oct, 2025 | 05:55pm • Source: BSE

Submission of Results for the 37th Annual general meeting held on 29th Sep, 2025

01 Oct, 2025 | 05:47pm • Source: BSE